home · filing · 0001193125-25-071309
8-K filed April 2, 2025, 7:59 PM ET
ticker IDYA
CIK 0001676725
leadership
confidence high
sentiment neutral
materiality 0.40
Director Susan Kelley to step down from IDEAYA board, move to advisory role
IDEAYA Biosciences, Inc.
Susan L. Kelley, M.D. will not stand for re-election at the 2025 annual meeting of stockholders.
She will resign from the Board immediately after the Annual Meeting.
Kelley intends to transition to Chair of the new Clinical Advisory Board expected before the meeting.
Board size will decrease to seven directors effective after the Annual Meeting.
Departure is not due to any disagreement with the Company's operations, policies, or practices.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Filed April 2, 2025, 7:59 PM ET
Dr. Kelley will resign from the Board at the end of her current term, which will conclude immediately after the Annual Meeting.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Susan L. Kelley, M.D. resigned as Director at IDEAYA Biosciences, Inc..
Action resigned
Role Director
Exact text from the filing
Dr. Kelley will resign from the Board at the end of her current term, which will conclude immediately after the Annual Meeting.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-25-071309
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.